Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(60.0%)
Early Phase 1
1(20.0%)
Phase 1
1(20.0%)
5Total
N/A(3)
Early Phase 1(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05679362Not ApplicableNot Yet Recruiting

Online Brief CBT Intervention for Women With PCOS

Role: collaborator

NCT04075149Early Phase 1Unknown

Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?

Role: collaborator

NCT03252522Phase 1Completed

Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study

Role: collaborator

NCT04119492Not ApplicableUnknown

DCD & ASD Imaging Intervention Study

Role: collaborator

NCT02904980Not ApplicableCompleted

The Effects of a Group-based Gaze Training Intervention for Children With Developmental Coordination Disorder

Role: collaborator

All 5 trials loaded